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100a Sunday, March 1, 2009Norepinephrine (NE) is a well-known physiological inhibitor of insulin secre-
tion in pancreatic b cells. We investigated modulation of exocytosis and endo-
cytosis by NE in INS 832/13 cells using whole-cell capacitance measure-
ments. Exocytosis was stimulated by depolarizing pulses from 70mV to
þ10mV of variable duration and was followed by compensatory endocytosis.
Inhibition of Ca2þ-evoked exocytosis by NE was overcome by increasing
Ca2þ influx, either by increasing the depolarizing pulse duration (up to
500ms) or by increasing the extracellular Ca2þ concentration up to 10mM.
When stimulated by a short train of 500ms pulses in the presence of NE
(5mM), robust exocytosis was observed but endocytosis was markedly in-
hibited. The NE inhibition of endocytosis was abolished by the a2-adrenergic
receptor antagonist yohimbine (10mM) and was not affected by PTX-treatment
(150ng/ml), demonstrating that NE inhibition of endocytosis is mediated via
the a2-adrenergic receptor and not via Gi and/or Go proteins. When a synthetic
peptide that mimicked the last 13 c-terminal amino acids of the Gza subunit
was dialyzed into the cells via the whole-cell patch pipette, NE inhibition
of endocytosis was fully blocked, suggesting that Gz may be mediating the in-
hibition. Single vesicle recordings by cell attached capacitance measurements
indicate that inhibition of endocytosis by NE is due to a decreased number of
endocytic events without a significant change in endocytic vesicle size. Fur-
ther analysis of fission pore kinetics revealed that NE selectively inhibited
the rapid fission events. Our findings establish a novel action for NE and sug-
gest the possibility that NE may modulate endocytosis in the central nervous
system and elsewhere.
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Owing to the non-amyloidogenic pathway of amyloid precursor protein (APP)
processing to produce neuroprotective and neurotrophic a-secretase-cleaved
soluble APP (sAPPa), and preclude the amyloidogenic pathway which pro-
duces neurotoxic amyloid-b peptide (Ab), increasing a-secretase activity and
sAPPa levels have been suggested as pharmacological approaches for treat-
ment of Alzheimer’s disease (AD). In this study, we demonstrated that cyto-
kines including TNFa, IL-1b and IFNg stimulated immortalized astrocytes
(DITNC cells) to secrete secretory phospholipase A2 type III (sPLA2-III)
into culture medium. When this conditioned medium was applied to differen-
tiated human neuroblastoma (SH-SY5Y cells), it enhanced sAPPa secretion
from cells. To further demonstrate the effect of sPLA2-III on sAPPa secretion,
SH-SY5Y cells were exposed to sPLA2-III from bee venom, which is homol-
ogous to mammalian sPLA2-IIIs, and hydrolyzed products of sPLA2 including
arachidonic acid (AA), lysophosphatidylcholine (LPC) and palmitic acid (PA).
We found that either sPLA2-III or AA, but not LPC and PA, increased mem-
brane fluidity, increased the localization of APP at the cell surface without
altering the total APP expression in cells, and enhanced sAPPa secretion in
SH-SY5Y cells. In addition, neither sPLA2-III nor AA altered the expressions
of a-secretases including ADAM 9, 10, and 17. APP has the motif which can
target to clathrin-coated pits. We demonstrated that monodansylcadaverine
(MDC), clathrin-mediated endocytosis inhibitor, can increase sAPPa secretion
from SH-SY5Y cells by reducing APP internalization. Based on these results,
sPLA2-III-enhanced sAPPa secretion is suggested to be a consequence in part,
due to increased membrane fluidity, and reduced APP internalization through
clathrin-mediated endocytosis. Further study will focus on the effect of
sPLA2-III on clathrin-mediated endocytosis.
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We are developing transparent multi-electrochemical electrode arrays on
microchips in order to automate measurement of quantal transmitter exocyto-
sis from individual neuroendocrine cells. Features of interest in amperometric
recordings of quantal exocytosis can be <1 pA in amplitude, therefore low
current noise is essential. Consequently we are seeking to understand the
relationship between current noise and working electrode area, series resis-
tance, bandwidth, and choice of fabrication materials. We have measured
the current power spectral density (PSD) from electrode arrays with working
areas that vary in size using a low-noise amplifier. Arrays are shielded frominterfering signals. The capacitance of the working Indium-Tin-Oxide elec-
trode varies linearly with area with a specific capacitance of 36 fF/mm2. In the
absence of an analyte, current noise is thermal in origin because the PSD is
well described by the Nyquist relationship: PSD ¼ 4kT times the Real part
of the electrode Admittance. We find the PSD amplitude scales ~linearly
with working electrode area and with frequency from ~30 Hz to at least 3
kHz. The dependence of the PSD on electrode area is similar for carbon-fiber
electrodes and our patterned chip electrodes, therefore the electrode material
and fabrication method are not key determinants of electrode noise. The
choice of material and thickness (>2 mm) for insulating the non-working areas
of the electrodes also does not affect the PSD. We conclude that the standard
deviation of current noise increases ~ linearly with recording bandwidth, and
microchip electrodes can achieve the same noise performance as carbon-fiber
microelectrodes.
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Exocytosis at synapses generally refers to fusion between vesicles and the
plasma membrane. Although fusion between vesicles, known as compound fu-
sion, occurs in non-neuronal secretory cells and has recently been proposed at
ribbon-type synapses, it remains unclear whether it exists, how it is mediated,
and what role it plays at the vast majority of synapses, where release occurs at
conventional active zones. Here we addressed this issue in rats and mice at
a large nerve terminal containing conventional active zones. High potassium
application induced giant capacitance up-steps at the release face of nerve ter-
minals, which were larger than the membrane capacitance of regular vesicles.
These giant up-steps were not comprised of several smaller steps, nor were they
bulk endocytic vesicles that had re-fused. High potassium application also in-
duced giant vesicle-like structures in nerve terminals and giant miniature
EPSCs (mEPSCs) that reflected release of a large amount of transmitter. The
giant up-steps, giant vesicle-like structures, and giant mEPSCs were abolished
by removing the extracellular calcium or by knocking out synaptotagmin II, the
calcium sensor mediating fusion at calyces. These results suggest that calcium
binding with synaptotagmin II mediates compound fusion and increases quan-
tal size. Compound fusion significantly contributed to the generation of a widely
observed synaptic plasticity, post-tetanic potentiation (PTP) of the EPSC, be-
cause 1) action potential trains that generated PTP also evoked giant up-steps
and increased the mEPSC amplitude, 2) the time course and the degree of
the mEPSC amplitude increase paralleled those of PTP, and 3) both the mEPSC
amplitude increase and PTP were abolished by the calcium buffer EGTA or
synaptotagmin II knockout. Our finding may be of wide application because in-
tense nerve activity, PTP, and giant miniature currents occur in physiological
conditions at many synapses.
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In neurons, SNARE proteins form a complex that drives membrane fusion
leading to neurosecretion. SNAP-25 is an integral part of the neuronal
SNARE complex and is clipped by the extremely toxic protease Botulinum
Neurotoxin type E (BoNT/E). SNAP-25 is thought to act in the plasma mem-
brane by forming a 1:1 complex with Syntaxin 1A which forms the binding
site for the vesicular SNARE, synaptobrevin. SNAP-25 is also found in the
vesicle membrane where its physiological role, if any, has yet to be defined.
We show that BoNT/E cuts SNAP-25 in rat brain synaptic vesicles (SVs) de-
creasing their fusion to model membranes (BLM) containing reconstituted
syntaxin 1A. We hypothesize that SNAP-25’s role in vivo may depend on
the lipid composition of the plasma and vesicular membranes. SNAP-25 is
the only SNARE protein with no membrane spanning domain however, it is
anchored in the membrane through the palmitoylation of one or more of its
cysteines residues. In order to examine how SNAP-25 functions under differ-
ent lipid conditions we used our planar lipid bilayer-base fusion system. Fu-
sion rates are determined for target membranes composed of PE:PC (7:3) and
with DPPC above and below its Tm. In order to simulate a more native neu-
ronal environment, cholesterol (up to 50mol%) is added to the membrane By
understanding the dynamics of the SNARE protein complex in different lipid
environment, we hope to understand more about how neurons utilize SNARE
proteins to release neurotransmitter.
